molecular marker for minimally invasive diagnostics of either cerebral tumours or inflammable diseases
The work group of Prof. Dr. Eckart Meese at Saarland University identified special features of tumour cells that could constitute a basis for an improved special diagnostic investigation. Tumour antigens were identified which trigger an immune reaction exclusively in patients with glioms or meningeoms. Based on this success re-search was extended on the fields of MS and COPD.
Compared with common procedures, the minimally invasive diagnosis, based on blood analysis, is a very cost-efficient method. Furthermore, this procedure means less inconveniences for the patient (complete blood count only).
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-6340
Contact
Dipl. Chem. Dagmar Vössing, Dipl.-Kfm. Axel Koch MBA, Dipl. Ing. Gerd Schneider
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Making diamonds at ambient pressure
Scientists develop novel liquid metal alloy system to synthesize diamond under moderate conditions. Did you know that 99% of synthetic diamonds are currently produced using high-pressure and high-temperature (HPHT) methods?[2]…
Eruption of mega-magnetic star lights up nearby galaxy
Thanks to ESA satellites, an international team including UNIGE researchers has detected a giant eruption coming from a magnetar, an extremely magnetic neutron star. While ESA’s satellite INTEGRAL was observing…
Solving the riddle of the sphingolipids in coronary artery disease
Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new…